Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo

Meri K. Tulic,Elisa Cavazza,Yann Cheli,Arnaud Jacquel,Carmelo Luci,Nathalie Cardot-Leccia,Hanene Hadhiri-Bzioueche,Patricia Abbe,Maéva Gesson,Laura Sormani,Claire Regazzetti,Guillaume E. Beranger,Cedric Lereverend,Caroline Pons,Abdallah Khemis,Robert Ballotti,Corine Bertolotto,Stéphane Rocchi,Thierry Passeron
DOI: https://doi.org/10.1038/s41467-019-09963-8
IF: 16.6
2019-05-16
Nature Communications
Abstract:T-cells play a crucial role in progression of autoimmunity, including vitiligo, yet the initial steps triggering their activation and tissue damage remain unknown. Here we demonstrate increased presence of type-1 innate lymphoid cells (NK and ILC1)-producing interferon gamma (IFNγ) in the blood and in non-lesional skin of vitiligo patients. Melanocytes of vitiligo patients have strong basal expression of chemokine-receptor-3 (CXCR3) isoform B which is directly regulated by IFNγ. CXCR3B activation by CXCL10 at the surface of cultured human melanocytes induces their apoptosis. The remaining melanocytes, activated by the IFNγ production, express co-stimulatory markers which trigger T-cell proliferation and subsequent anti-melanocytic immunity. Inhibiting the CXCR3B activation prevents this apoptosis and the further activation of T cells. Our results emphasize the key role of CXCR3B in apoptosis of melanocytes and identify CXCR3B as a potential target to prevent and to treat vitiligo by acting at the early stages of melanocyte destruction.
multidisciplinary sciences
What problem does this paper attempt to address?